Drug recall
CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC…
FDA recall event 63874 · Class III · Genentech, Inc.
Key facts
| Event ID | 63874 |
|---|---|
| Recall numbers | D-097-2013 |
| Recalling firm | Genentech, Inc. |
| Product type | Drugs |
| Products | CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Short Fill: some bottles contained less than 120-count per labeled claim. |
| Initiation date | Sep 27, 2012 |
| Report date | Dec 26, 2012 |
| Termination date | Nov 20, 2014 |
| City | South San Francisco |
| State | CA |
| Country | United States |
| FEI number | 2917293 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: